BRIEF published on 11/13/2025 at 16:05, 3 months 28 days ago The Vanguard Group Discloses Position in Bluefield Solar Fund Form 8.3 Takeover Code Vanguard Group Shareholding Bluefield Solar
PRESS RELEASE published on 11/13/2025 at 16:04, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc as of 12 Nov 2025. No other parties involved in the offer Irish Takeover Panel The Vanguard Group Financial Disclosure Interest Disclosure Mural Oncology Plc
BRIEF published on 11/13/2025 at 16:03, 3 months 28 days ago Vanguard Group's Interest in Spire Healthcare Takeover Code Securities Disclosure Vanguard Group Spire Healthcare Shareholding
BRIEF published on 11/13/2025 at 16:02, 3 months 28 days ago Vanguard Group Discloses Position in Alphawave IP Group Takeover Code Vanguard Group Public Disclosure Securities Interest Alphawave IP
PRESS RELEASE published on 11/13/2025 at 16:02, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.34% interest in Greencore Group plc's 1p ordinary securities. Disclosure made under Rule 8.3 of the Takeover Code Disclosure Rule 8.3 Takeover Code Vanguard Group Greencore Group Plc
BRIEF published on 11/13/2025 at 16:01, 3 months 28 days ago Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Dowlais Group
PRESS RELEASE published on 11/13/2025 at 16:00, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses 1.24% stake in Bluefield Solar Income Fund Limited. Form 8.3 filed on 13 November 2025 Form 8.3 The Vanguard Group Inc. Financial Disclosure Stake Disclosure Bluefield Solar Income Fund Limited
BRIEF published on 11/13/2025 at 15:59, 3 months 28 days ago The Vanguard Group's Disclosure on Empiric Student Property Stake Takeover Code Securities Disclosure Vanguard Group Shareholding Empiric Student Property
PRESS RELEASE published on 11/13/2025 at 15:58, 3 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.57% interest in Spire Healthcare Group plc according to Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Rule 8.3 Takeover Code Interest Disclosure Spire Healthcare Group Plc
BRIEF published on 11/13/2025 at 15:58, 3 months 28 days ago The Vanguard Group's Position in Petershill Partners plc Ordinary Shares The Vanguard Group Takeover Code Securities Disclosure Petershill Partners
Published on 03/12/2026 at 13:16, 48 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 03/12/2026 at 13:00, 1 hour 4 minutes ago Justera Announces Director and Interim CEO Appointments
Published on 03/12/2026 at 12:30, 1 hour 34 minutes ago Nextech3D.ai Signs Three-Year Enterprise 3D Modeling and Augmented Reality E-Commerce Contract Valued at Approximately $175,000
Published on 03/12/2026 at 12:30, 1 hour 34 minutes ago Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million
Published on 03/12/2026 at 13:51, 12 minutes ago REPLY: The Board of Directors approved the draft financial statements for the year 2025
Published on 03/12/2026 at 13:45, 18 minutes ago Vietnam Airlines Steps Up Market Promotion Efforts in Europe
Published on 03/12/2026 at 13:20, 43 minutes ago Eightco (NASDAQ: ORBS) Secures $125M in Institutional Commitments Led by Bitmine (NYSE: BMNR), Cathie Wood's ARK Invest, and Payward to Expand into Next Generation Technology
Published on 03/12/2026 at 13:05, 58 minutes ago Phemex TradFi Hits $10B Monthly Volume, Advancing Cross-Market Trading Infrastructure
Published on 03/12/2026 at 13:00, 1 hour 4 minutes ago Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
Published on 03/12/2026 at 10:55, 3 hours 8 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 6 hours 34 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/11/2026 at 18:30, 19 hours 33 minutes ago Filing of the 2025 TF1 Universal Registration Document
